Skip to main content

Table 1 Baseline demographics and disease characteristics

From: Predictors of hepatitis C treatment outcomes in a harm reduction-focused primary care program in New York City

Total n (%) Treatment completion (n = 329) P value Return for SVR 12 test (n = 302) P value
Yes No   Yes No
302 (92) 27 (8)   226 (75) 76 (25)  
Age
Mean 53.5 53.2 0.882 54.3 51.3 0.059
Range 20–77 36–82   24–77 20–70  
20–30 19 (6) 0 (0) 0.36 11 (5) 8 (11) 0.076
31–50 85 (28) 11 (41)   62 (27) 23 (30)  
51–70 187 (62) 15 (56)   142 (63) 45 (60)  
71–82 11 (4) 1 (4)   11 (5) 0 (0)  
Gender n (%)    0.862    0.53
Male, n (%) 219 (73) 20 (74)   166 (73) 53 (70)  
Female, n (%) 83 (27) 7 (26)   60 (27) 23 (30)  
Race/ethnicity    0.71    0.854
African American or Black, n (%) 71 (24) 4 (15)   54 (24) 17 (22)  
Hispanic, n (%) 117 (39) 13 (48)   85 (37) 32 (42)  
White, n (%) 58 (19) 5 (19)   43 (19) 15 (20)  
Other, n (%) 56 (19) 5 (19)   44 (19) 12 (16)  
Cirrhotic, n (%) 58 (19) 6 (22) 0.704 50 (22) 8 (11) 0.026
Insurance type   0.525   0.033   
Private, n (%) 12 (4) 2 (7)   11 (5) 1 (1)  
Medicaid, n (%) 207 (69) 21 (78)   145 (64) 62 (82)  
Medicare, n (%) 43 (14) 1 (4)   39 (17) 4 (5)  
Medicare + medicaid, n (%) 39 (13) 3 (11)   30 (13) 9 (12)  
Uninsured, n (%) 1 (0) 0 (0)   1 (0) 0 (0)  
Uses medicaid, n (%) 246 (81) 24 (89) 0.33 175 (77) 71 (93) 0.002
HIV coinfection, n (%) 8 (3) 2 (7) 0.168 4 (2) 4 (5) 0.101
Diabetes, n (%) 47 (16) 3 (11) 0.537 42 (19) 5 (7) 0.013
Other comorbidity, n (%) 182 (60) 14 (52) 0.393 146 (64) 36 (47) 0.008
Current substance use, n (%) 90 (30) 10 (37) 0.434 65 (29) 25 (33) 0.496
Current psychiatric Illness, n (%) 82 (27) 10 (37) 0.273 66 (29) 16 (21) 0.167
Lifetime substance use, n (%) 282 (93) 25 (93) 0.129 208 (92) 74 (97) 0.106
Lifetime psychiatric Illness, n (%) 253 (84) 24 (89) 0.141 186 (82) 67 (88) 0.231
Housing status    0.003    0.777
Stable, n (%) 243 (80) 15 (56)   181 (80) 62 (82)  
Unstable, n (%) 59 (20) 12 (44)   45 (20) 14 (18)  
Incarceration history    0.166    0.831
 < 5 Years ago, n (%) 64 (21) 10 (37)   48 (21) 16 (21)  
 > 5 years ago, n (%) 159 (53) 11 (41)   117 (52) 42 (55)  
Never, n (%) 79 (26) 6 (22)   61 (27) 18 (24)  
Methadone use, n (%) 196 (65) 20 (74) 0.336 138 (61) 58 (76) 0.016
  1. Statistically significant p-values (p-value < 0.05) were bolded